Self-Study Module - EM202235

Menopause Management

Created 4/11/2022   Expired 4/11/2025
1.Learner Information
By signing this form, I attest that I have completed the participant requirements for this CME activity. Any patient/case information will be kept confidential.
(Required.)
2.Objectives were met for this activity, and this activity has enhanced my overall knowledge or abilities.(Required.)
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
3.Please rate this conference(Required.)
4.Was this activity engaging and/or interactive
5.Are the written materials helpful, and will they be useful references in the future?
6.This CE Activity….(Required.)
Met my learning needs
Was relevant to my current scope of practice
Contributed to my professional growth.
Helped me learn skills and concepts that will allow me to be effective and strategic in my practice
Allowed me to increase my connections with peers.        
Provided me with new ideas and resources.
Select all that apply
7.Identify any specific changes that you plan to implement in your professional practice as a result of information you obtained as an attendee of this CME activity:
None - Retired from Practice          
Patient Work-up
Treatment Plans
Patient Education
Select  all that apply.
8.This activity changed, enhanced, or improved my:(Required.)
Knowledge
Competency
Performance
Patient Outcomes
Communication skills    
Practice-based systems
System-based practices
Select all that apply
9.Activity was free of commercial bias
(Required.)
10.Activity was evidence-based(Required.)
11.What are the impediments to change?
Cost
Insurance/reimbursement issues
Lack time to assess/counsel patients
Patient compliance issues
Lack of administrative support/resources
Lack of consensus of professional guidelines
Select all that apply.
12.What is one concept you learned from this activity and will you be making any changes to your practice?(Required.)
True
False
Postmenopause is defined by the final menstrual period (FMP) and confirmed after 1 year of no menstrual bleeding
Vasomotor symptoms last for a median of 2 to 3 years.    
Endometrial protection is not needed with local doses of estrogen.
13.Comments on this activity, or suggestions for CME topics.